Clinical trial
A Prospective, Multi-Center, Evaluator-Blinded Study Evaluating the Safety and Effectiveness of the Renuvion APR Device to Improve the Appearance of Lax Tissue in the Neck and Submental Region
NCT04146467 is registered in ClinicalTrials.gov with Apyx Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-Center, Evaluator-Blinded Study Evaluating the Safety and Effectiveness of the Renuvion APR Device to Improve the Appearance of Lax Tissue in the Neck and Submental Region
- Lead sponsor
- Apyx Medical
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 26, 2019
- Completion date
- February 28, 2022
- Enrollment
- 82 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
lax skin